림프절 전이 양성 및 음성 유방암종의 CD44 변이형들의 발현 차이에 관한 비교 연구
Comparison of the Expression of Variants of CD44 between Node-positive and Node-negative Breast Carcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : The purpose of this study is to determine the value of CD44 and its splice variants as markers for the metastatic potential of infiltrating ductal carcinomas of the breast. Methods : Tissue samples of infiltrating ductal carcinoma of the breast were examined for the expression of standard CD44 (CD44H) and s CD44 isoforms, v3, v4-5 and v6 in 41 node-positive and 31 node-negative cases. The immunohistochemistry results were correlated with other clinicopathologic parameters, and these results were correlated with accompanying high grade and non-high grade DCIS areas of the tumors in both node-positive and node-negative cases. Results : The expression of CD44 in the invasive tumor areas and in the metastatic foci of the lymph nodes showed a statistically significant correlation. The expression of CD44H in the invasive tumor areas and the DCIS area showed a statistically significant correlation in the lymph node (-) group. There was statistical significance between the CD44 H and CD44v3 expressions and the histologic grade of the invasive tumor in the cases with positive lymph nodes. There was no statistical significance between CD44 expression and lymph node metastasis, tumor size and type of tumor margin. Conclusions : We conclude that changes in the CD44 expression in breast cancer occur early in breast carcinogenesis, and this is involved in tumor differentiation, but we could not establish any correlation between the expression of the CD44 variant isoforms and the metastasis of breast cancer.
참고문헌 (28)
- Gunthert U, "CD44:a multitude of isoforms with diverse functions", 184, pp.47~63 (1993)
- Screaton GR, "Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons", 89, pp.12160~4 (1992)
- Hofmann M, "CD44 splice variants confermetastatic behavior in rats:homologous sequences are expressedin human tumor cell lines", 51, pp.5292~7 (1991)
- Jackson DG, "Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain", 267, pp.4732~9 (1992)
- Stamenkovic I, "The hematopoietic and epithelial forms of CD44 are distinct polypeptides with differentadhesion potentials for hyaluronate-bearing cells", 10, pp.343~8 (1991)
- Herron LR, "A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man", pp.1195~202
- Gunthert U, "A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells", 65, pp.13~24 (1991)
- Gunthert U, "Are CD44 variant isoforms involved in human tumour progression", 24, pp.19~42 (1995)
- Rudzki Z, "CD44 and the adhesion of neoplastic cells", 50, pp.57~71 (1997)
- Matsumura Y, "Significance of CD44 gene products for cancer diagnosis and disease evaluation", 340, pp.1053~8 (1992)
- Tanabe KK, "Expression of CD44R1 adhesion molecule in colon carcinomas and metastases", 341, pp.725~6 (1993)
- Iida N, "New CD44 splice variants associated with human breast cancers", 162, pp.127~33 (1995)
- Sinn HP, "Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44", 36, pp.307~13 (1995)
- Heider KH, "A human homologue of the rat metastasis associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps", pp.227~33
- Shimoyama Y, "Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas", 49, pp.2128~33 (1989)
- Joensuu H, "Glycoprotein CD44 expression and its association with survival in breast cancer", 143, pp.867~74 (1993)
- Yahyaoui O, "Relationship between lymphatic metastasis in breast and cervix cancers and the level of CD44-H expression evaluated by an immunohistochemical method", 29, pp.422~6 (2001)
- Kalish ED, "A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression", 4, pp.~8 (1999)
- Bankfalvi A, "Gains and losses of CD44 expression during breast carcinogenesis and tumour progression", 33, pp.107~16 (1998)
- Bankfalvi A, "Immunophenotypicand prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression:a comparative study with CD44", 34, pp.25~34 (1999)
- Perin T, "Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast", 32a, pp.1148~55 (1996)
- Friedrichs K, "CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer", 55, pp.5424~33 (1995)
- Charpin C, "Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas", 28, pp.289~96 (1997)
- Sanchez Lockhart M, "Splice variant expression of CD44 in patients with breast and ovarian cancer", 8, pp.145~51 (2001)
- Berner HS, "Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas", 42, pp.546~54 (2003)
- Guriec N, "CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma", 14, pp.434~9 (1996)
- Foekens JA, "Prognostic value of CD44 variant expression in primary breast cancer", 84, pp.209~15 (1999)
- Nunez MI, "Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size > 2 cm in infiltrating ductal carcinomas of the breast", 11, pp.220~2 (1996), Int J Biol Markers